Non-seminomatous ovarian germ cell tumours in children.

[1]  C. Patte,et al.  Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Gadner,et al.  Teratomas in infancy and childhood. , 1998, Medical and pediatric oncology.

[3]  J. Mann,et al.  UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group. , 1998, Medical and pediatric oncology.

[4]  U. Göbel,et al.  Alpha1-Fetoprotein (AFP) Reference Values in Infants up to 2 Years of Age , 1998 .

[5]  D. Ellison,et al.  The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland , 1997, Cancer.

[6]  M. Burt,et al.  Mediastinal growing teratoma syndrome. , 1997, The Annals of thoracic surgery.

[7]  G. Rustin,et al.  Surveillance policy for stage I ovarian germ cell tumors. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Salazar-Martínez,et al.  Conservative surgery for ovarian cancer and effect on fertility , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  C. Bokemeyer,et al.  A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  S. Culine,et al.  Is there a role for second‐look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy , 1996, Journal of surgical oncology.

[11]  G. Rustin,et al.  Chemotherapy for ovarian germ cell tumours. , 1996, European journal of cancer.

[12]  L. F. Lopes,et al.  Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: results of the Brazilian Germ Cell Tumor Study. , 1995, Medical and pediatric oncology.

[13]  R. Zepp,et al.  Ovarian carcinoma: value of CT in predicting success of debulking surgery. , 1995, AJR. American journal of roentgenology.

[14]  D. Gershenson,et al.  Management of early ovarian cancer: germ cell and sex cord-stromal tumors. , 1994, Gynecologic oncology.

[15]  J. P. Geisler,et al.  GROWING TERATOMA SYNDROME AFTER CHEMOTHERAPY FOR GERM CELL TUMORS OF THE OVARY , 1994, Obstetrics and gynecology.

[16]  S. Liao,et al.  Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Einhorn,et al.  Clinical trials in testicular cancer , 1993 .

[18]  N. Geller,et al.  Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Bukowski Rm.  Management of advanced and extragonadal germ-cell tumors. , 1993 .

[20]  N. Marina,et al.  Treatment of childhood germ cell tumors: Review of the St. Jude experience from 1979 to 1988 , 1992, Cancer.

[21]  S. Saxman.  Salvage therapy in recurrent testicular cancer. , 1992, Seminars in oncology.

[22]  M. Krailo,et al.  Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Swerdlow,et al.  Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. , 1991, British Journal of Cancer.

[24]  A. Horwich,et al.  'JEB'--a carboplatin based regimen for malignant germ cell tumours in children. , 1990, British Journal of Cancer.

[25]  J. Mann,et al.  Results of the United Kingdom children's cancer study group's malignant germ cell tumor studies , 1990, Cancer.

[26]  C. Patte,et al.  Optimal treatment of clinical stage I yolk sac tumor of the testis in children. , 1986, Journal of pediatric surgery.

[27]  H. Shingleton,et al.  Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A gynecologic oncology group study (a final report) , 1985, Cancer.

[28]  J. Young,et al.  Incidence of the histologic types of ovarian cancer: the U.S. Third National Cancer Survey, 1969-1971. , 1977, Gynecologic oncology.

[29]  H. Norris,et al.  Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases , 1976, Cancer.

[30]  B. Eisenstein,et al.  Malignant teratoma of the ovary. , 1960, The Grace Hospital bulletin.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[32]  D. Harms,et al.  Treatment of malignant testicular tumors in childhood: results of the German National Study 1982-1992. , 1994, Medical and pediatric oncology.

[33]  U. Göbel,et al.  BEP/VIP bei Kindern und Jugendlichen mit malignen nichttestikulären Keimzelltumoren , 1993 .

[34]  J. Woodruff,et al.  Germ cell tumors in children: gonadal and extragonadal. , 1991, Medical and pediatric oncology.

[35]  H. Jürgens,et al.  Treatment of germ cell tumors in children: results of European trials for testicular and non-testicular primary sites. , 1990, Critical reviews in oncology/hematology.

[36]  A. Talerman.  GERM CELL TUMOURS , 1985, Annales de pathologie.